Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Home
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • ATMP
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Podcast
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Interviews
    • Meetings reports
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Home
  • Pharmaceuticals
      • ATMP
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Product information
      • Regulatory procedures
    • AdobeStock_540926170
      Gene therapy gives
      hope to patients
      with ‘butterfly skin’
    • RR-May-2023-Cover-FULL
      May 2023 – Contents
    • NUTRACEUTICALS
      Regulatory guidelines for
      nutraceuticals in India
  • Veterinary
    • RR-May-2023-Cover-FULL
      May 2023 – Contents
    • AdobeStock_223465811 (1)
      First anaemia drug for cats given
      ‘expanded conditional approval’
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
    • RR-May-2023-Cover-FULL
      May 2023 – Contents
    • Understanding the key components of a clinical evaluation
      Understanding key components
      of a clinical evaluation
    • AdobeStock_497948986 (1)
      Successful transition of your ISO 13485 QMS from MDD/IVDD to MDR/IVDR
  • Industry news
      • Industry news
        • Read latest news
        • Podcast
        • Video
    • Podcast-artwork-Webvision
      Conversations:
      Regulating Vaxzevria:
      The world’s first COVID-19 vaccine
    • AdobeStock_577204899
      Illegal vapes found
      to contain lead and
      nickel: TOPRA Fellow
    • AdobeStock_540926170
      Gene therapy gives
      hope to patients
      with ‘butterfly skin’
  • Commentary
      • Editorials
      • Letters to the Editor
    • Legalise-Cannabis
      Part 4. UK routes to registration for medicinal cannabis
    • Cannabis&Doctors
      Part 3. The medical applications of cannabis
    • Cannabis&Law
      Part 2. Regulatory background of medicinal cannabis in EU and UK
  • Collections
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Interviews
      • Meetings reports
      • Symposium 2022
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
      • Symposium 2021
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More navigation items

Product Information Stories

  • Patient information, why do things go wrong?

    Patient information — why do things go wrong?

    2023-02-07T09:26:00+00:00By Rory Littlebury

  • AdobeStock_180072866

    Part 1: EU reclassification (Rx to OTC switch) regulatory framework – what are the key challenges for industry and how might these be overcome?

    2022-06-22T14:53:00+01:00By Sarah Landra (née Laird)

  • AdobeStock_294542021

    Electronic leaflet pilot in Belgium and Luxembourg hospitals

    2022-03-23T11:07:00+00:00By Nathalie Lambot, Marie Vande Ginste

  • Regulatory Rapporteur Editorial board
  • Future focus topics
  • Glossary
  • Privacy policy
  • Search the archive
  • TOPRA membership
  • What is regulatory affairs?
  • ISSN 1742-8955

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Issues
  • Contact us
  • Topics A-Z
  • Contributors A-Z
  • Copyright © 2023 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud